SLC16A3 and neoplasm: ALKBH5 deletion alters the metabolic profile of tumor cells and reduces lactate levels in the tumor immune microenvironment by altering the splicing and expression of target genes (Mct4/Slc16a3) via an m6A-dependent mechanism.118